Somatostatin receptor 2A in gliomas: Association with oligodendrogliomas and favourable outcome

Somatostatin receptor subtype 2A (SSTR2A) is a potential therapeutic target in gliomas. Data on SSTR2A expression in different glioma entities, however, is particularly conflicting. Our objective was to characterize SSTR2A status and explore its impact on survival in gliomas classified according to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiviniemi, Aida, Gardberg, Maria, Kivinen, Katri, Posti, Jussi P., Vuorinen, Ville, Sipilä, Jussi, Rahi, Melissa, Sankinen, Matti, Minn, Heikki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564754/
https://www.ncbi.nlm.nih.gov/pubmed/28467778
http://dx.doi.org/10.18632/oncotarget.17097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564754/
https://www.ncbi.nlm.nih.gov/pubmed/28467778
http://dx.doi.org/10.18632/oncotarget.17097

Ejemplares similares